YTHDF2 upregulation and relocation dictate CD8 T cell polyfunctionality in tumor immunity

Haiyan Zhang,Xiaojing Luo,Wei Yang,Zhiying Wu,Zhicong Zhao,Xin Pei,Xue Zhang,Chonghao Chen,Josh Haipeng Lei,Qingxia Shi,Qi Zhao,Yanxing Chen,Wenwei Wu,Zhaolei Zeng,Huai-Qiang Ju,Miaozhen Qiu,Jun Liu,Bin Shen,Minshan Chen,Jianjun Chen,Chu-Xia Deng,Rui-Hua Xu,Jiajie Hou
DOI: https://doi.org/10.1101/2024.07.11.603088
2024-07-16
Abstract:Epigenetic traits impact the antitumor function of CD8 T cells, yet whether and how RNA methylation programs engage in T cell immunity is poorly understood. Here we show that the -methyladenosine (m A) RNA reader YTHDF2 is highly expressed in early effector or effector-like CD8 T cells and is partially distributed in the nucleus. YTHDF2 loss in T cells exacerbates tumor progression and confers unresponsiveness to PD-1 blockade in mice and humans. In addition to initiating RNA decay for mitochondrial fitness, YTHDF2 can orchestrate chromatin regulation to promote T cell polyfunctionality. YTHDF2-mediatd preservation of gene transcription arises from the interaction of YTHDF2 with IKZF1/3. Accordingly, immunotherapy-induced efficacy could be largely restored in YTHDF2-deficient T cells through combinational use of lenalidomide. Moreover, m A recognition is fundamental for YTHDF2 translocation to the nucleus and autoregulation at the RNA level. Thus, YTHDF2 coordinates epitranscriptional and transcriptional networks to potentiate T cell immunity.
Immunology
What problem does this paper attempt to address?